Skip to main content
OpenTrials
Completed

NCT Number: NCT05462665

Evaluation of the Intravenous Tissue Plasminogen Activator Treatment Algorithm of Nursing Intern Students

Intravenous (IV) tissue plasminogen activator (tPA) is one of the key elements of acute ischemic stroke. In this study, acute stroke patients maximum benefit from the treatment, intravenous tissue plasminogen activator (IV tPA) minimizing the errors related to the treatment of acute ischemic stroke patients of nursing students from clinical practice guides published on the treatment of It is aimed to be informed and to standardize nursing interventions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Nervous System Diseases Stroke Vascular Diseases

Age range

18 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Ozge Soydaner

Izmir, Turkey (Türkiye)

About this study

Time management in acute stroke patients is possible with a multidisciplinary approach and team members who have received specific training for acute stroke patients. Studies have shown that the maximum result of treatment for acute stroke patients depends on nurses' ability to identify disease symptoms, plan and apply symptom-specific nursing care. There is evidence that the multidisciplinary presence of stroke teams in stroke units and the delivery of coordinated care during the acute phase improve patient outcomes . Coordinated care by the stroke team improves patient outcomes, reduces hospital costs, reduces patient readmission, and improves patient care quality.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Intern nursing student at Dokuz Eylül University

Exclusion criteria

Those who did not agree to participate in the study Those who were not be intern

Treatment and study plan

theory training

Behavioral

theory training

Other names: tPA treatment knowledge of nursing students will increase

theory and simulation training

Behavioral

theory and simulation training

Other names: tPA treatment knowledge of nursing students will increase

Primary outcomes

  1. self-efficacy scale

    Time frame: Change from baseline in Intravenous Tissue Plasminogen Activator Treatment knowledge and 2 weeks after intervention

    Effectiveness change of Intravenous tissue plasminogen activator treatment knowledge after theoric teaching

  2. simulation scale

    Time frame: 2 weeks after simulation training

    evaluation the simulation design

  3. tPA treatment information form

    Time frame: Change from baseline in Intravenous Tissue Plasminogen Activator Treatment knowledge and 2 weeks after intervention

    Effectiveness change of Intravenous tissue plasminogen activator treatment knowledge after simulation and theoric teaching

Sponsors and collaborators

Lead sponsor

Dokuz Eylul University

Other

Registry information

Official study title

Evaluation of the Intravenous Tissue Plasminogen Activator Treatment Algorithm of Nursing Intern Students and Evaluation of the Efficiency of Simulation Method in the Development of Self-Efficacy Proficiency Levels

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Jul 18, 2022
Registry last updated
Jul 18, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.